Jacob S. Sherkow
Fellow, Center for Law and the Biosciences
Jacob S. Sherkow is a Fellow at Stanford Law School's Center for Law and the Biosciences. Jake's primary research focus concerns the intersection of biotechnology and the law, with an emphasis on patent law and agency regulation. His legal scholarship on these topics has appeared in the Michigan, Iowa, and BYU Law Reviews, as well as the Yale Law Journal Online, while his scientific scholarship has appeared in Science, Nature Biotechnology, and JAMA (Internal Medicine). In addition, Jake is the author of several articles in the popular press, including pieces in the New York and Los Angeles Times. Jake also received a 2013 Leonardo Da Vinci Research Grant, hosted by the Center for Protection of Intellectual Property, for his upcoming work on interagency conflict and cooperation in patent litigation.
Prior to coming to Stanford, Jake was a patent litigation associate at Gibson, Dunn & Crutcher in New York where he, and a team of attorneys, won the Frank Wheat Memorial Award for pro bono service. Jake was also a law clerk for Judge Nicholas G. Garaufis on the U.S. District Court for the Eastern District of New York and an intern for Judge Paul L. Friedman on the U.S. District District Court for the District of Columbia.
Jake graduated cum laude from the University of Michigan Law School in 2008, where he served as an editor of the Michigan Law Review and was the recipient of the Fred L. Leckie and James N. Adler Scholarships. Jake holds a Masters in Biotechnology from Columbia University; his thesis focused on social, legal, and ethical aspects of race-specific heart medications. He also holds a Bachelor of Science from McGill University, where he majored in Molecular Biology and English Literature.
In addition to his legal training, Jake has several years of experience as a research scientist in molecular biology. He has held scientific research positions at Columbia University, the University of Edinburgh, McGill University, the Montreal General Hospital, the Montreal Neurological Institute, and Mount Sinai Medical Center.